- Nevada COVID-19 vaccinations rise to 1 in 6 people statewide (apnews.com)
Nevada health officials reported Monday that about 1 in 6 people statewide has received at least a first dose of a COVID-19 vaccine since shots became available in mid-December...“I do think progress is starting to finally click and continue to increase,” said James English, COVID-19 response operations chief in Washoe County, where state statistics show 16.8% of residents have received their first shot and 9.8% have been fully vaccinated...READ MORE
- Study: More than 8 in 10 adults prefer their local pharmacist over mail order (chaindrugreview.com)
A large majority of American adults prefer to get their prescription drugs from a local pharmacist instead of a mail order service, mainly because of the personal relationship, according to a new national survey released today by the National Community Pharmacists Association...“Most Americans clearly are not willing to substitute personal care for the perception of convenience,”...When asked why, 36 percent say their pharmacist knows them better than a mail order company. Thirty-two percent say their pharmacist answers questions and provides counsel on how to use the drugs. Another 15 percent worry their drugs will get lost in the mail, exposed to the elements, or stolen...READ MORE
- Gilead cuts jobs in California, moving some to new North Carolina business center (fiercepharma.com)
Gilead Sciences’ new business service center is a win for North Carolina but comes with some losses for the company's home state of California...The Foster City-based pharma plans to cut 178 jobs in California effective May 30...It’s “the latest example of a major Bay Area company moving workers to a cheaper location”...Half of the jobs are expected to shift to Gilead's now-underway Research Triangle Park service center in North Carolina...Under a North Carolina economic development and jobs grant program, Gilead can earn up to $10 million in reimbursement payments over 12 years through the project. North Carolina estimates it will see an annual economic gain of more than $39 million...READ MORE
- FDA panel endorses Johnson & Johnson vaccine in 22-0 vote (chaindrugreview.com)
The Food and Drug Administration advisory committee endorsed Johnson & Johnson’s coronavirus vaccine late Friday afternoon...The vaccine appears widely effective against the virus and is especially good at preventing severe cases...And because the vaccine is given as a single dose and is easy to ship, it presents an appealing profile for public health officials struggling to vaccinate hard-to-reach or skeptical populations...READ MORE
- CVS to invest $12.4M in affordable housing in Phoenix (fiercehealthcare.com)
CVS Health is investing $12.4 million to build 60 units of affordable housing in south Phoenix...The development will be built in a neighborhood where 79% of residents identify as Black or Latino...The funding is part of CVS' commitment to invest $600 million over five years to address racial inequality and the social determinants of health in Black communities..."When people have access to high-quality, affordable housing and services like preventive screenings, it puts them in a better position to take care of their health and manage chronic disease," said David Casey, senior vice president and chief diversity officer at CVS Health...READ MORE
- How might Pharma buddy up with Alexa? Bayer Consumer’s first interactive voice ad is food for thought (fiercepharma.com)
Alexa, show me the future of drug advertising? Bayer Consumer Health's first-ever Alexa interactive ad allows consumers to buy an OTC product by talking to the Amazon device—and may foreshadow broader trends in the industry...The U.K. ad for Bayer’s Berocca Boost, a vitamin and caffeine tablet, is running as a trial during programming streamed by Global...Launching the app brings up voice options to either order the product or hear more information about it. If the listener chooses to order, Alexa asks whether they’d like to use a default payment method and address. One yes later, Berrocca Boost is on its way and the original radio program returns...While dropping an OTC product into an Amazon cart via voice app is a long way from fulfilling a physician-ordered prescription medicine the same way, the Bayer trial foreshadows what's possible even in the more regulated pharma world...READ MORE
- Getting your COVID shot at CVS or Walgreens? Prepare for an onslaught of texts and coupons as the pharmacies plan to use customer data to ‘keep in touch’ and promote services (dailymail.co.uk)
CVS, Walgreens and Walmart are enrolling customers in patient systems in order for them to book vaccine appointments...Perk of data allows these chains to use information to promote their stores and services, which includes coupons and promotions, and tailor marketing...After customers create profiles for Walgreens, they get marketing emails and agree to let Walgreens 'automatically collect information about you'...READ MORE
- Patent protection barriers not holding back vaccine production: drug groups say (reuters.com)
Manufacturing capacity and ingredients shortages are the main bottlenecks to expanding COVID-19 vaccine production, several global drug groups said...not patents that some critics are demanding be removed...“IP (intellectual property) rights is not the issue,” said Thomas Cueni, who heads the International Federation of Pharmaceutical Manufacturers and Associations...“The bottlenecks are the capacity, the scarcity of raw materials, scarcity of ingredients, and it is about the know-how.”...READ MORE
- FDA’s inspection woes to grow if agency doesn’t address COVID-19 backlog: GAO (fiercepharma.com)
The Government Accountability Office has concerns about the FDA's widening inspection backlog. COVID-19 certainly amplified the problem, but the issues had been mounting long before last March...As the FDA looks to honor lockdown rules and protect its staffers, the agency has largely paused inspections since the pandemic started last spring, conducting only those deemed “mission-critical.” In fact, the FDA was unable to complete more than 1,000 planned inspections in 2020—and that backlog will likely grow with time, the U.S. Government Accountability Office (GAO) said in a release...READ MORE
- J&J Covid-19 Vaccine Authorized for Use in U.S. (msn.com)Johnson & Johnson's COVID-19 vaccine scores FDA authorization, adding key third shot to U.S. supply (fiercepharma.com)
The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, was authorized for use...the third issued by the U.S. Food and Drug Administration, will give health authorities a desperately needed new source of doses as they scramble to ramp up inoculations ahead of elusive emerging strains...J&J said it has begun shipping the vaccine to the U.S. government, which is managing allocation and distribution. That indicates first doses could be administered during the coming week...READ MORE










